sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks PHT-427

PHT-427

CAS No.:
1191951-57-1
Catalog Number:
AG000IAU
Molecular Formula:
C20H31N3O2S2
Molecular Weight:
409.6090
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
≥98%
1 week
United States
$98
- +
10mg
≥98%
1 week
United States
$136
- +
25mg
≥98%
1 week
United States
$244
- +
50mg
99%
1 week
United States
$373
- +
100mg
99%
1 week
United States
$590
- +
200mg
99%
1 week
United States
$1040
- +
Product Description
Catalog Number:
AG000IAU
Chemical Name:
PHT-427
CAS Number:
1191951-57-1
Molecular Formula:
C20H31N3O2S2
Molecular Weight:
409.6090
MDL Number:
MFCD18384970
IUPAC Name:
4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide
InChI:
InChI=1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23)
InChI Key:
BYWWNRBKPCPJMG-UHFFFAOYSA-N
SMILES:
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1
Properties
Complexity:
474  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
409.186g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
409.607g/mol
Monoisotopic Mass:
409.186g/mol
Rotatable Bond Count:
14  
Topological Polar Surface Area:
109A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.4  
Literature
Title Journal
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Molecular cancer therapeutics 20100301
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry 20091001
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. Cancer research 20090615
Structure, regulation and function of PKB/AKT--a major therapeutic target. Biochimica et biophysica acta 20040311
Role of Akt signaling in vascular homeostasis and angiogenesis. Circulation research 20020628
Properties